Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Would it be right to say the Sable shareholders would have nothing at all if Contango had not acquired Lubu I see some say offered .2p for their shares and some hint of 1p elsewhere.
On a brief look of a holding just before suspension it equated to about 1.1 bill Sable shares in issue, with the CGO holding being 98m, so 11 times less, IE a direct value a 7p SP of 0.64p, however CGO has been lower warrants at 5p and 3p too, with a start price of under 4p making .64 about .32, so why was .2p so derisory as some say. When trying to sell 98m shares would cause a dive in the SP, so no doubt under the circs it was seen as a good offer v the zero that would have been achieved otherwise and matched the suspension price.
As one has pointed out the amount owned by CGH has been dropping transferred as payment for 'work'. Perhaps it will continue.
Relevant but not, as the SP is the same as pre the coal price rise, as is the forecast based on those prices. I note the CV was forecast to be 28CV but comes in as 30/31CV upping it's viability. Hence the number talking to them.
Next quarter starts Dec 1st (production comment) and no doubt a deal will be signed.
Testing the theory without hindsight.
In theory either after hours or first thing tomorrow large late reports will go through to show the supply to an MM.
The only holding that could sell notifiable is .4% above 1 percent, as about 7m or so seem to have come via late reports recently if it's a notifiable holder then A Tr1 should appear very shortly.
The 7 mill figure ignores what look like triple printed identical numbers on one day
Cooper I list a large number of shares some I don't know why and I forget re many. I noted a 1.2m early morning pre 7am trade on Ygen so I'd thought I'd look to see it's an after hours buy or sell.
I saw the SP dip from 19p to 14p hits twice by the market H1 update then the actual news.
If you check after hours trades at the back end of last week you will see big numbers. It didn't make sense why the SP was holding but now it can be seen that buys are being made below the mid price (the majority today).
So imo the dip is a supply which is at old with the H2 comments.
I'm not the obsessive Covid type I just noted they have extra revenue going there to offset other sectors but in the updates the other sectors seem to have recover in H2 making the Covid revenue extra.
BUT on Covid they now have the parts type testing got authority and are listed now on the gov list which follows on from International bans , 10 day isolation of you arrive with a negative test, 5 days if you have test here and it's negative.
So on paper, in the news where they stated revenue already returning H2, plus other businesses coming through then it's fair to think H2 will see growth which the market doesn't expect as it was focusing on 5% growth H1 and the international part hit H1.
Revenues hit by Covid disrupting testing in other parts of their business. Either way mid this year it should pick up as things ease, along with clear comments that H2 will be far better than H1.
So it seems the covid revenue would offset H2 other products but they say that's going well too
our COVID-19 products and services generated revenues of GBP0.5m in H1 and have already exceeded that in the first two months of H2.
The info that things are going well is in news if anyone noticed.
Oct 20
Delays in launching new customer sites in key new international markets such as the USA and Japan have recently been resolved and strong momentum has been established in the early part of the second half of the financial year.
Revenues from the Company's UK COVID-19 testing services and international Clarigene(R) SARS-CoV-2 diagnostic product started to build in the latter part of H1 and are showing strong growth in the early part of the second half of the financial year.
The second quarter saw a return to more normal trading patterns with strong momentum entering the second half. Sales of other reproductive health products proved more resilient due to our end customers being focused in the UK and in public hospitals in Europe,
Yourgene's UK COVID-19 testing service is expanding rapidly and from the beginning of October 2020 is now operating at its full capacity of 10,000 tests per month. Capacity is being further expanded to 20,000 tests per month which is due to come on stream in the third quarter. This will increase COVID-19 testing revenue potential to approximately GBP1m per month
Then there is the £500k from the NCYT link up H1 stated as more than £500k in the first 2 months of H2.
So all there to read pointing to far more positive H2 with £1.5m to £2m probably front the link up and if 10k capacity hit £1m per month for 20k then that's £3m for 6 months ignoring the capacity increase then add on the return of momentum of sales hit.
So H2 looks very promising as mentioned in the news run 26th Oct on>
So it's not inside info it's in the news, people don't tend to read all the news and digest what is in it.
Put ii's off. ???
They already have 67% of the company about 70% taken up with them and the directors.
That leaves 8 mill shares for PIs to hold.
It's illiquid there are no free shares about hence the spread and inability to buy/sell in bulk.
15 PE rate for £1 mill profit 57p on the SP.
EG
Belluscura: The FDA hit Plano, Texas devicemaker Belluscura with a Form 483 for failing to properly document evaluations of potential suppliers to ensure that their products conformed to specified requirements.
In a Nov. 19-29, 2018 inspection, the agency noted that the facility evaluated prospective suppliers using a questionnaire prior to an audit but had failed to do that for two of its suppliers.
Having been found to have certain failures before I suppose the FDA now give them extra attention on applications
The failure part is documented by the FDA
This one took 4 months
510(K) Number K191159
Device Name Concentrator With Single Battery Pack, Carry Bag With Shoulder Strap, Back Pack Shoulder Straps, A, POC1 USB Bluetooth Dongle, POC1 Invacare Mobile Medical Application Accessory For Use On IOS And Android Devices, Invacare Platinum Mobile Oxygen Concentrator With Connectivity
Applicant
Invacare Corporation
One Invacare Way
Elyria, OH 44035
Others down the list up to a year to get clearance. Tek tried last year there is PDF somewhere about issues FDA.
Just saying re FDA procures not always straightforward and 90 days etc.
Feel free to check yourself
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm
Type in Kingon in name then Belluscura, there is way to see all such kit recently given FDA clearance.
So as in the news the guidance is H1, if it was close then they surely would have said so.
90 days
Looking like it's not the 90 days otherwise they would not have said H1 having been specific in Feb announcement
Bella were supposed to get it last year it seems and have had some issues re the FDA before.
This was last year same product Tek news.
"We are delighted to see that Belluscura has strengthened its balance sheet and is on track to likely receive FDA clearance later this year.
The broker note on the topic
Into 2019, several companies are expecting to see further milestones including Belluscura receiving 510(K) clearance from the FDA for its POC system in Q3,
This year it seems 90 days missed which means questions asked re the submission at a guess. Questions stop the clock.
In any case you can check to see if it's been given the clearance on the FDA website, no such clearance listed up to today.
Kingon had one cleared recently, similar kit, but not Bella yet.
I did point out long ago it was just hype trash, but as many know its pointless trying to give rampant bulls (sucked in by a company) the real facts. I had, prior to them ever arriving had a good look at the Helium in Montana and had comms with Bo Sears who at the time was Mr Helium of the US. The Helium in the area was not viable. Bo has spent many a long hour looking at projects across Montana including gather pure Helium play over by the Sweetgrass arch. All Mendell has done has is coop up some old leases where others had looked and walked away, then threw a lot of hype in. Besides that one of the counties they were making claims on has very poor options on produced water reinfection. It was just BS spin.
The oil news states they need the new wells to be as good as the first ones just to meet their overheads. What can bee seen form the Cogcc site is that no well shave produced anything since early August including the original 2. Those 2 original wells saw a sudden drop in suggest and we re shut in, perhaps related to the fracking.
I also understand one of the directors was under a restriction not to flat over here and he ignored it. Also a suggestion of an issue with one of one of them which would explain the exuberant nature of news.
Digging out those sort of facts then can lead some to be negative.
Let's see how the new wells go, they need to be good.
I have no interest in shorting, just facts. When I spot BS I try to warn others, but it generally falls on deaf ears.
Just saying ( may be covered here) details on advfn. Cogcc data shows all HNR wells now shut in. You may wish to check if that is correct ot not
Oh he moved to the UK great that must mean the tech works under industrial conditions. So he couldn't;t buy one share in all the years because he need it all to move to the UK. lmao. That's a daft point just like the excuse of patent are expensive which someone posted in response to no patent. World beater, worth billions but don't bother protecting it. Nice to be in charge of virtually no one on �66k per year. Plus whatever they get from the �20k per month milk off into Waste2. Same old B S that was said about the Pyromex kit until they had to admit it was a complete failure.
You think a couple of weeks running in the years it has been around with constant changes is proof it works. Good luck with that one and I hope you don't all lose your cash. For now I'd favour that is what is going to happen. You keep going on about Hydrogen for vehicles as does the CEO. The costs for one unit for that is over �10 mill as per the presentation (unit plus PSA). The �10 mill figure is an example as costs per unit in the case of multiple units. WTF is �5 mill going to come from never mind �10 mill. With those figures notifiable holders will be diluted out of the notification range. What does the CEO lose if the company goes tits up. How may shares does he have? How is the patent going for this world changing tech? Tumbleweed time and that apparently doesn't bother anyone invested.
Brighter It's my view through good research that this is likely to go bust. Do you read the FT article when the CEO said he is off while the going is good? Not once have they stated the tech works. The FT comment say he is down to zero bonus one part of which is scale up. I can only say it so many times. If it goes tits up please get hold of me and I'll try to help you get some cash back via the nomad who has failed to warn the market about lies and misinformation. Can you tell me how they produce GNPs. I'm just interested to know if any investor has the slightest clue how they do it.
Yes and he has shares so he would tip it. Fund arise looks nailed on BIT who with as there are no obvious funds on board. Death spiral last chance fund shop Darwin perhaps. We'll have to wait and see.
No action on this one anywhere, what am I missing on the negatives it seems to be undervalued v prospects and recent news.
Admitting the lies won't fix the tech. CVD is not easy and this was CVD on a nano scale onto nano sized substrates. All warnings (hidden under the hype) stated the tech was not proven and that line has not changed since the very first finance update. The only time the tech risk warning changed was IPO to the first finance update at which point the warning was more serious. Shame they didn't clearly warn those in the IPO that it was unproven tech.
The other major point is the tech doesn't work for quakity GNPs at commercial levels. Then when looking at synthetic GNPS for 3 companies the lateral sizes are poor which appears to be a potential issue. As far as I'm aware there is no public TDS for AGM graphene to establish the layer level and lateral sizes. The CPI tender for 1kg of synthetic graphene had lateral sizes beyond any such product I have found to date. The CPI built the AGM kit yet no sign of the award of the 1kg tender to AGM as yet.